Localization and Density of Transferrin Binding Sites in the Nigrostriatal System of Control Subjects and Patients with Parkinson’s Disease

[1]  K. Earle.  Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. , 1968, Journal of neuropathology and experimental neurology.

[2]  Wade K. Smith,et al.  Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization , 1989, Annals of neurology.

[3]  Y Agid,et al.  Are dopaminergic neurons selectively vulnerable to Parkinson's disease? , 1993, Advances in neurology.

[4]  P Riederer,et al.  Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.

[5]  D. Mash,et al.  Characterization and Distribution of Transferrin Receptors in the Rat Brain , 1990, Journal of neurochemistry.

[6]  Y. Agid,et al.  Distribution of 125I‐Ferrotransferrin Binding Sites in the Mesencephalon of Control Subjects and Patients with Parkinson's Disease , 1993, Journal of neurochemistry.

[7]  C. Morris,et al.  Brain iron homeostasis. , 1992, Journal of inorganic biochemistry.

[8]  C. W. Olanow,et al.  Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.

[9]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[10]  P. Riederer,et al.  Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? , 1989, Acta neurologica Scandinavica. Supplementum.

[11]  K. Jellinger,et al.  Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.

[12]  R. Kalaria,et al.  Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease , 1992, Brain Research.

[13]  P. Aisen.  Entry of iron into cells: A new role for the transferrin receptor in modulating iron release from transferrin , 1992, Annals of neurology.

[14]  E. Schon,et al.  Nonidentical distribution of transferrin and ferric iron in human brain , 1988, Neuroscience.

[15]  K. Jellinger,et al.  Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease , 1992, Annals of neurology.

[16]  Y. Agid,et al.  Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis , 1991, Journal of neurochemistry.

[17]  A. Graybiel,et al.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.

[18]  C. Marsden,et al.  Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.

[19]  C. Pert,et al.  Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Nicholas Willson,et al.  An autoradiographic study of the uptake and distribution of iron by the brain of the young rat , 1990, Brain Research.

[21]  D. Mash,et al.  Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice , 1991, Experimental Neurology.